iBio, Inc. IBIO
NASDAQ IBIO
$0.82 +0.04 (+5.67%)
At close: Nov 11, 2026 · 4:00 PM EST

iBio (IBIO) Other Non-Current Liabilities (2009 - 2023)

Updated

iBio (IBIO) reported Other Non-Current Liabilities of $263,000 for fiscal Q1 2024 (quarter ended Sep 30, 2023), down 50.1% from the prior quarter.

Analysis

iBio (IBIO) Other Non-Current Liabilities (2009 - 2023) Analysis & Trends

At the end of FY2023 (ended Jun 30, 2023), iBio posted Other Non-Current Liabilities of $527,000.

  • Per Business Quant data, the three fiscal quarters before Q1 2024 came in at $527,000 (Q4 2023), $791,000 (Q3 2023) and $1.07 million (Q2 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 iBio 118.23 Mn -174.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 263,000.00
Jun 30, 2023 527,000.00
Mar 31, 2023 791,000.00
Dec 31, 2022 1.07 Mn
Mar 31, 2013 16,668.00
Dec 31, 2012 125,500.00
Sep 30, 2012 760,608.00
Jun 30, 2012 520,000.00
Mar 31, 2012 1.31 Mn
Dec 31, 2011 396,509.00
Sep 30, 2011 1.48 Mn
Jun 30, 2011 4.19 Mn
Mar 31, 2011 6.14 Mn
Dec 31, 2010 5.99 Mn
Sep 30, 2010 3.16 Mn
Jun 30, 2010 1.71 Mn
Mar 31, 2010 799,204.00
Dec 31, 2009 740,819.00
Sep 30, 2009 1.18 Mn
Mar 31, 2009 983,000.00
API Access

iBio Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=IBIO&period=max&api_key=YOUR_API_KEY